Fox News: Experimental Gel Partially Protects against Genital Herpes

By Rueters

An experimental vaginal gel containing a drug used to treat the AIDS virus could prevent half of cases of genital herpes, according to a study done in South Africa.

Among women who used tenofovir gel, the annual rate of infection with the genital herpes virus, known as herpes simplex virus type 2 or HSV-2, was 10.2 percent versus a rate of 21 percent for women who used a placebo gel.

Huffington Post: Tackling Non-Communicable Diseases to Avoid Premature Deaths

By Bjørn Lomborg

In rich countries, the biggest causes of death are strokes, heart attacks and cancer, accounting for more than two-thirds of all deaths. But for the poorer world, people often assume that infectious diseases like diarrhea, tuberculosis, AIDS, malaria, measles and tetanus are the biggest killers. That is no longer true. While they are still substantial threats, broader availability of medication and vaccines along with higher living standards has caused such communicable diseases to drop dramatically to below 9 million deaths each year.

NBC News: New Long-Acting Malaria Drug Looks Promising

By Maggie Fox

Researchers have developed a new, long-acting malaria drug that they believe may help fight one of the world's biggest killers.

The drug, still known by its experimental name "DSM265," can stop the malaria parasite at several stages in its life cycle, the researchers report in the journal Science Translational Medicine. Tests in people have begun.

34 Million Children's Lives Saved by Health Investments

A report from the Institute for Health Metrics and Evaluation (IHME) at the University of Washington and the UN Secretary-General’s Special Envoy for Financing the Health Millennium Development Goals and for Malaria

More than 34 million children’s lives have been saved since 2000 because of investments in child health programs at a cost of as little as $4,205 per child, according to a new analysis in The Lancet.

Pages